Olympus Announces CEO Succession Process

December 20, 2024

TOKYO, December 20, 2024 - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced the initiation of a comprehensive CEO succession process following the resignation of the former CEO. As previously announced, Yasuo Takeuchi, Director, Representative Executive Officer and Executive Chairperson, has been carrying out the CEO duties while the search for a permanent successor is underway.

Consistent with the company's commitment to good corporate governance, the Nominating Committee of the Board (NC) will lead the process. The NC has formed an Advisory Search Committee (ASC) to identify and recommend the best candidates for the CEO position. The ASC comprises a mix of management and independent board members with extensive experience in Medtech, executive hiring and onboarding, and corporate governance.

The ASC is tasked with assisting in selecting a recruitment firm, defining search criteria, reviewing candidates, and making recommendations to the Nominating Committee. Additionally, the ASC will assist the Compensation Committee of the Board in establishing an appropriate compensation package for the new CEO. The ASC members include:

• Gary John Pruden, Chair of the Committee, Outside Director
• Jimmy C. Beasley, Outside Director
• Luann Marie Pendy, Outside Director
• Yasuo Takeuchi, Director, Representative Executive Officer, Executive Chairperson, and ESG Officer, Olympus Corporation
• Shigeto Ohtsuki, Executive Officer and Chief Human Resources Officer, Olympus Corporation
  
• Neil Boyden Tanner, Executive Officer and Global General Counsel, Olympus Corporation

Upon the recommendation of the ASC and through extensive research, the Board has engaged a leading global executive recruitment firm to assist in evaluating internal and external candidates. Identified candidates will be thoroughly vetted by the recruitment firm and interviewed by the ASC and NC, and the finalist(s) will be reviewed and approved by the Board of Directors.
Olympus Corporation is committed to completing the CEO succession process as swiftly and efficiently as possible to ensure continued leadership and growth.

About Olympus

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp.